Skip to main content
Top
Published in: Ophthalmology and Therapy 2/2018

Open Access 01-12-2018 | Commentary

"Minimally Invasive Glaucoma Surgery (MIGS) Is a Poor Substitute for Trabeculectomy"—The Great Debate

Authors: Philip Bloom, Leon Au

Published in: Ophthalmology and Therapy | Issue 2/2018

Login to get access

Abstract

Surgical treatment for glaucoma has undergone a dramatic change over the last decade. Trabeculectomy has been the main surgical procedure worldwide for almost 50 years. However, there is a growth in development of new novel devices and surgical techniques designed to lower intraocular pressure in a less invasive fashion. The term minimally invasive glaucoma surgery (MIGS) has been coined and is the subject of investment, debate and, increasingly, research. The position of MIGS in the glaucoma treatment paradigm is yet to be clearly defined and its ability to replace conventional filtration surgery remains debatable. In this paper two glaucoma specialists were invited to debate the motion that “MIGS is a poor substitute for trabeculectomy”.
Literature
1.
go back to reference Kirwan JF, Lockwood AJ, Shah P, Macleod A, Broadway DC, King AJ, McNaught AI, Agrawal P. Trabeculectomy in 21st century: a multicentre analysis. Ophthalmology. 2013;120(12):2532–9.CrossRef Kirwan JF, Lockwood AJ, Shah P, Macleod A, Broadway DC, King AJ, McNaught AI, Agrawal P. Trabeculectomy in 21st century: a multicentre analysis. Ophthalmology. 2013;120(12):2532–9.CrossRef
2.
go back to reference Khaw PT. More flow study. Clin Exp Ophthalmol. 2002;30(Sup):A45. Khaw PT. More flow study. Clin Exp Ophthalmol. 2002;30(Sup):A45.
4.
go back to reference Tan SZ, Walkden A, Au L. One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative management. Eye. 2018;32:324–32.CrossRef Tan SZ, Walkden A, Au L. One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative management. Eye. 2018;32:324–32.CrossRef
5.
go back to reference Moisseiev E, Loewenstein A, Yiu G. The suprachoroidal space: from potential space to a space with potential. Clin Ophthalmol. 2016;10:173–8.CrossRef Moisseiev E, Loewenstein A, Yiu G. The suprachoroidal space: from potential space to a space with potential. Clin Ophthalmol. 2016;10:173–8.CrossRef
7.
go back to reference Ahmed I. MIGS and the FDA: what’s in a name (editorial)? Ophthalmology. 2015;122(9):1737–9.CrossRef Ahmed I. MIGS and the FDA: what’s in a name (editorial)? Ophthalmology. 2015;122(9):1737–9.CrossRef
8.
go back to reference Manasses DT, Au L. The new era of glaucoma micro-stent surgery. Ophthalmol Ther. 2016;5(2):135–46.CrossRef Manasses DT, Au L. The new era of glaucoma micro-stent surgery. Ophthalmol Ther. 2016;5(2):135–46.CrossRef
9.
go back to reference Edmunds B, Thompson JR, Salmon JF, Wormald RP. The national survery of trabeculectomy III. Early and late complications. Eye (Lond). 2002;16(3):297–303.CrossRef Edmunds B, Thompson JR, Salmon JF, Wormald RP. The national survery of trabeculectomy III. Early and late complications. Eye (Lond). 2002;16(3):297–303.CrossRef
10.
go back to reference King AJ, Rotchford AP, Alwitry A, Moodie J. Frequency of bleb manipulations after trabeculectomy surgery. Br J Ophthalmol. 2007;91(7):873–7.CrossRef King AJ, Rotchford AP, Alwitry A, Moodie J. Frequency of bleb manipulations after trabeculectomy surgery. Br J Ophthalmol. 2007;91(7):873–7.CrossRef
11.
go back to reference Rodriguez-Una I, Azuara-Blanco A, King AJ. Survey of glaucoma surgical preferences and post-operative care in the United Kingdom. Clin Exp Ophthalmol. 2017;45(3):232–40.CrossRef Rodriguez-Una I, Azuara-Blanco A, King AJ. Survey of glaucoma surgical preferences and post-operative care in the United Kingdom. Clin Exp Ophthalmol. 2017;45(3):232–40.CrossRef
12.
go back to reference Kerr NM, Wang J, Barton K. Minimally invasive glaucoma surgery as primary stand-alone surgery for glaucoma. Clin Exp Ophthalmol. 2017;45(4):393–400.CrossRef Kerr NM, Wang J, Barton K. Minimally invasive glaucoma surgery as primary stand-alone surgery for glaucoma. Clin Exp Ophthalmol. 2017;45(4):393–400.CrossRef
13.
go back to reference Fea AM, Ahmed II, Lavia C, Mittica P, Consolandi G, Motolese I, Pignata G, Motolese E, Rolle T, Frezzotti P. Hydrus microstent compared to selective laser trabeculoplasty in primary open angle glaucoma: one year results. Clin Exp Ophthalmol. 2017;45(2):120–7.CrossRef Fea AM, Ahmed II, Lavia C, Mittica P, Consolandi G, Motolese I, Pignata G, Motolese E, Rolle T, Frezzotti P. Hydrus microstent compared to selective laser trabeculoplasty in primary open angle glaucoma: one year results. Clin Exp Ophthalmol. 2017;45(2):120–7.CrossRef
14.
go back to reference García-Feijoo J, Rau M, Grisanti S, Grisanti S, Höh H, Erb C, Guguchkova P, Ahmed I, Grabner G, Reitsamer H, Shaarawy T, Ianchulev T. Supraciliary micro-stent implantation for open-angle glaucoma failing topical therapy: 1-year results of a multicenter study. Am J Ophthalmol. 2015;159(6):1075–81.CrossRef García-Feijoo J, Rau M, Grisanti S, Grisanti S, Höh H, Erb C, Guguchkova P, Ahmed I, Grabner G, Reitsamer H, Shaarawy T, Ianchulev T. Supraciliary micro-stent implantation for open-angle glaucoma failing topical therapy: 1-year results of a multicenter study. Am J Ophthalmol. 2015;159(6):1075–81.CrossRef
15.
go back to reference Ogata-Iwao M, Inatani M, Takihara Y, Inoue T, Iwao K, Tanihara H. A prospective comparison between trabeculectomy with mitomycin C and phacotrabeculectomy with mitomycin C. Acta Ophthalmol. 2013;91(6):e500–1.CrossRef Ogata-Iwao M, Inatani M, Takihara Y, Inoue T, Iwao K, Tanihara H. A prospective comparison between trabeculectomy with mitomycin C and phacotrabeculectomy with mitomycin C. Acta Ophthalmol. 2013;91(6):e500–1.CrossRef
16.
go back to reference Tan SZ, Walkden A, Au L (2017) One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative management. Eye (Lond) 32:324–32.CrossRef Tan SZ, Walkden A, Au L (2017) One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative management. Eye (Lond) 32:324–32.CrossRef
17.
go back to reference Schlenker MB, Gulamhusein H, Conrad-Hengerer I, Somers A, Lenzhofer M, Stalmans I, Reitsamer H, Hengerer FH, Ahmed IIK. Efficacy, safety, and risk factors for failure of standalone Ab Interno gelatin microstent implantation versus standalone trabeculectomy. Ophthalmology. 2017;124(11):1579–88.CrossRef Schlenker MB, Gulamhusein H, Conrad-Hengerer I, Somers A, Lenzhofer M, Stalmans I, Reitsamer H, Hengerer FH, Ahmed IIK. Efficacy, safety, and risk factors for failure of standalone Ab Interno gelatin microstent implantation versus standalone trabeculectomy. Ophthalmology. 2017;124(11):1579–88.CrossRef
18.
go back to reference Shahid H, Salmon JF. Fifteen-year mortality rate and visual outcome in newly diagnosed chronic open-angle glaucoma. Br J Ophthalmol. 2013;97(2):235–6.CrossRef Shahid H, Salmon JF. Fifteen-year mortality rate and visual outcome in newly diagnosed chronic open-angle glaucoma. Br J Ophthalmol. 2013;97(2):235–6.CrossRef
19.
go back to reference Mercieca K, Shevade B, Anand N. Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study. Eye (Lond). 2015;29(11):1495–503.CrossRef Mercieca K, Shevade B, Anand N. Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study. Eye (Lond). 2015;29(11):1495–503.CrossRef
Metadata
Title
"Minimally Invasive Glaucoma Surgery (MIGS) Is a Poor Substitute for Trabeculectomy"—The Great Debate
Authors
Philip Bloom
Leon Au
Publication date
01-12-2018
Publisher
Springer Healthcare
Published in
Ophthalmology and Therapy / Issue 2/2018
Print ISSN: 2193-8245
Electronic ISSN: 2193-6528
DOI
https://doi.org/10.1007/s40123-018-0135-9

Other articles of this Issue 2/2018

Ophthalmology and Therapy 2/2018 Go to the issue